CA Patent

CA2675622A1 — Hgf preparation

Assigned to Kringle Pharma Inc · Expires 2008-08-28 · 18y expired

What this patent protects

Disclosed is an HGF preparation containing HGF and purified sucrose. This HGF preparation is characterized in that it remains stable even when stored for a long time.

USPTO Abstract

Disclosed is an HGF preparation containing HGF and purified sucrose. This HGF preparation is characterized in that it remains stable even when stored for a long time.

Drugs covered by this patent

Patent Metadata

Patent number
CA2675622A1
Jurisdiction
CA
Classification
—
Expires
2008-08-28
Drug substance claim
No
Drug product claim
No
Assignee
Kringle Pharma Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.